B Braun D5353-5224 - Metronidazole Injection USP 500mg (5mg/mL), 100mL (Rx) - Antibacterial and Antiprotozoal Injection for Treating Infections,24/CS (Continental US+HI Only, Excluding IN and ND)
The B Braun D5353-5224 Metronidazole Injection USP 500mg (5mg/mL), 100mL, is a sterile, ready-to-use solution designed for the intravenous administration of metronidazole, an effective antibiotic and antiprotozoal agent. Metronidazole is commonly used to treat a variety of infections caused by susceptible anaerobic bacteria, protozoa, and certain other pathogens. This injectable formulation provides a convenient and effective method for delivering metronidazole to patients who require intravenous therapy for infections that are difficult to treat orally.
The 500mg dose in a 100mL solution (5mg/mL) allows healthcare professionals to administer the appropriate dosage based on the patient's condition, ensuring effective treatment. This product is ideal for hospitals, outpatient clinics, and other medical environments where intravenous administration is necessary for infections resistant to other treatments or in patients who cannot take oral medications.
Key Benefits
The B Braun D5353-5224 Metronidazole Injection offers several important benefits:
- Broad-Spectrum Activity: Metronidazole is effective against a wide range of anaerobic bacteria and protozoa, making it a versatile treatment for infections caused by these pathogens.
- Convenient IV Administration: The 100mL pre-mixed solution allows for intravenous administration, providing a rapid and reliable method of delivering the medication directly into the bloodstream for immediate therapeutic effects.
- Effective for Serious Infections: Commonly used for severe infections such as intra-abdominal infections, gynecological infections, and certain types of skin and soft tissue infections, as well as for protozoal infections like giardiasis and trichomoniasis.
- 500mg Dose (5mg/mL): The 500mg dose is appropriate for many infections requiring IV administration, ensuring that patients receive the correct therapeutic level of medication.
- Sterile, Ready-to-Use: The solution is pre-mixed and sterile, reducing the time and complexity of preparation for healthcare providers, and ensuring a consistent and accurate dosage.
Compatibility and Applications
B Braun D5353-5224 Metronidazole Injection is compatible with a variety of intravenous infusion systems and is typically used in the following medical scenarios:
- Anaerobic Infections: Metronidazole is widely used to treat infections caused by anaerobic bacteria, including abdominal infections, pelvic infections, and soft tissue infections.
- Protozoal Infections: This injection is effective in treating protozoal infections, such as giardiasis, trichomoniasis, and amoebiasis.
- Gynecological and Intra-Abdominal Infections: Metronidazole is often used in gynecological infections, including pelvic inflammatory disease, and is also a key treatment for intra-abdominal infections like peritonitis or diverticulitis.
- Surgical Prophylaxis: Metronidazole is sometimes used as part of a broader antibiotic regimen for surgical prophylaxis to prevent postoperative infections, particularly after surgeries involving the gastrointestinal tract.
Usage Guidelines
To ensure the proper and safe use of the B Braun D5353-5224 Metronidazole Injection, healthcare professionals should follow these guidelines:
- Dosage and Administration:Administer the metronidazole solution via intravenous infusion or direct injection according to the patients clinical condition and the prescribing healthcare providers instructions.
- Typical adult dosage is 500mg every 8 hours for infections, but the exact dosage and frequency should be tailored to the specific infection and patient needs.
- Infusion Rate: The recommended infusion rate should be carefully followed to avoid adverse reactions. For direct intravenous injection, the infusion should be administered slowly.
- Monitor for Adverse Effects: Monitor patients for any potential adverse reactions, including allergic reactions, gastrointestinal symptoms, and signs of neurotoxicity, which can occur with prolonged high-dose therapy.
- Single Use Only: The product is for single use only. Once the solution has been opened or administered, dispose of the remaining contents according to medical waste disposal guidelines.
- Do Not Mix with Certain Solutions: Metronidazole should not be mixed with certain other medications or solutions. Consult the prescribing information and ensure compatibility before co-administering with other IV drugs.
Certifications, Safety Standards, and Regulatory Approvals
The B Braun D5353-5224 Metronidazole Injection complies with the necessary FDA approval and CE certifications, ensuring it meets the stringent safety and quality standards required for injectable medications. These certifications validate that the product has undergone rigorous testing for safety, efficacy, and manufacturing consistency, making it suitable for clinical use in treating infections.
Comparison with Competitor Products
The B Braun D5353-5224 Metronidazole Injection distinguishes itself from competitor products through its pre-mixed, ready-to-use solution, reducing preparation time and ensuring accurate dosing. Many competitors require preparation or dilution before use, which may increase the risk of dosing errors and complications.
Additionally, the B Braun product is packaged in a convenient 100mL volume with 5mg/mL concentration, making it easier to adjust the dosage according to the patients needs. This formulation is particularly advantageous in hospital settings, where rapid administration and consistent dosing are critical for patient safety and therapeutic success.
Typical User Profile and Application Scenarios
This product is typically used by healthcare professionals such as doctors, nurses, and infectious disease specialists in hospitals, outpatient clinics, and other healthcare settings. It is most commonly administered in:
- Critical Care Settings: Ideal for treating patients with severe or life-threatening infections in ICUs, emergency departments, or surgical recovery rooms.
- Infectious Disease Management: Used in both the outpatient and inpatient treatment of a variety of infections caused by anaerobic bacteria or protozoa.
- Surgical Settings: Often administered as part of prophylactic treatment or postoperative care for patients undergoing abdominal, pelvic, or gastrointestinal surgeries.
Best Practices for Use and Maintenance
To ensure optimal patient outcomes and safety when using the B Braun D5353-5224 Metronidazole Injection, healthcare professionals should:
- Monitor Treatment Progress: Regularly assess the patient's response to therapy, including monitoring for signs of infection resolution and potential side effects.
- Adjust Dosage: Based on the infection and patient response, adjust the dosage and infusion rate as needed, following clinical guidelines.
- Prevent Infection: Always use sterile techniques when preparing and administering the solution to prevent contamination and ensure patient safety.
- Assess for Interactions: Be aware of potential drug interactions, especially with other medications that may increase the risk of side effects such as neurotoxicity.
Regulatory and Safety Information
The B Braun D5353-5224 Metronidazole Injection is manufactured to the highest standards and is FDA-approved for intravenous use in the treatment of infections. It also meets CE certification requirements, confirming that it complies with European Union safety, quality, and performance standards.
How to Order
Ordering the B Braun D5353-5224 Metronidazole Injection is simple. Add the product to your cart and proceed through the secure checkout process. For bulk orders or additional inquiries, please contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page. Our team is available to assist you with any questions or special requests regarding this product.
